By Mariam Sunny April 22 (Reuters) - A delay in a Medicare pilot to cover obesity drugs due to health insurers' hesitation to ...

Medicare has delayed its BALANCE program for weight-loss drugs like Wegovy. Discover the new 'bridge program' that will offer ...

Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.

The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...

The Trump administration announced that it is indefinitely delaying the implementation of the Medicare Part D portion of the ...

In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

Manufacturers whose medical devices have been FDA designated as Class III breakthrough devices -- those addressing an unmet ...

The US Government will now pick up the cost of weight loss drugs offered through the Medicare GLP-1 Bridge scheme until 31 ...

Louisville companies Cornbread Hemp and Alliant Purchasing are part of a new Medicare pilot program for cannabis products.

Dr. Mehmet Oz announced an initiative, requiring all 50 states to audit their Medicaid provider networks in a move marking a ...